Jiangsu Hengrui Medicine Co., Ltd. (600276.SS)
CNY 46.57
(-0.04%)
CNY 46.57
(-0.04%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 7.64 Billion | 1.26 Billion | 4.21 Billion | 3.43 Billion | 3.81 Billion | 2.77 Billion |
| Net Income | 4.27 Billion | 3.81 Billion | 4.48 Billion | 6.3 Billion | 5.32 Billion | 4.06 Billion |
| Depreciation & Amortization | 704.63 Million | 577.89 Million | 520.4 Million | 448.38 Million | 618.52 Million | 379.41 Million |
| Deferred income taxes | -98.47 Million | -22.1 Million | -93.38 Million | 18.78 Million | 46.55 Million | -22.02 Million |
| Stock-based compensation | 166.65 Million | 29.2 Million | 143.8 Million | 312.81 Million | 184.41 Million | 296.23 Million |
| Change in working capital | 2.38 Billion | -2.87 Billion | -783.16 Million | -3.41 Billion | -2.01 Billion | -1.75 Billion |
| Other non-cash items | 279.3 Million | -267.32 Million | -52.87 Million | -237.85 Million | -348.98 Million | 89.43 Million |
| Investing Cash Flow | 1.22 Billion | 390.28 Million | -546.26 Million | 1.79 Billion | -1.94 Billion | -2.85 Billion |
| Investments in PPE | -1.48 Billion | -1.99 Billion | -1.66 Billion | -554.32 Million | -561.35 Million | -529.1 Million |
| Acquisitions | 0.29 | 36.04 Million | 358.11 Million | 557.88 Million | 562.55 Million | 532.66 Million |
| Investment purchases | -17.08 Million | -7.44 Billion | -13.2 Billion | -27.63 Billion | -28.56 Billion | -11.47 Billion |
| Sales/Maturities of investments | 2.7 Billion | 9.76 Billion | 14.3 Billion | 29.98 Billion | 27.18 Billion | 9.14 Billion |
| Other Investing Activities | 20.18 Million | 20.21 Million | -341.99 Million | -554.32 Million | -561.35 Million | -529.1 Million |
| Financing Cash Flow | -3.14 Billion | -318.77 Million | -998.32 Million | 291.18 Million | -718.5 Million | -368.39 Million |
| Debt repayment | -1.26 Billion | -1.26 Billion | -31.05 Million | - | - | - |
| Dividends payments | -1.01 Billion | -1.01 Billion | -1.06 Billion | -1.01 Billion | -810.88 Million | -368.24 Million |
| Common Stock Repurchased | -827.26 Million | -398.02 Million | -274.07 Million | -11.97 Million | -4.63 Million | -9.29 Million |
| Common Stock Issuance | - | -861.97 Million | 305.12 Million | - | - | - |
| Other Financing Activities | -861.59 Million | 3.21 Billion | 67.92 Million | 1.32 Billion | 97.01 Million | -147.14 Thousand |
| Accounts receivables | 2.03 Billion | -2.28 Billion | -868.26 Million | -3.48 Billion | -2.89 Billion | -2.12 Billion |
| Accounts payables | 315.32 Million | -510.97 Million | 809.69 Million | 222.12 Million | 1.41 Billion | 633.62 Million |
| Inventory | 129.1 Million | -52.67 Million | -631.21 Million | -173.61 Million | -581.7 Million | -244.13 Million |
| Other working capital | -98.47 Million | -22.1 Million | -93.38 Million | 18.78 Million | 46.55 Million | -1.51 Billion |
| Cash at beginning of period | 14.53 Billion | 13.12 Billion | 10.46 Billion | 5.03 Billion | 3.86 Billion | 4.26 Billion |
| Cash at end of period | 20.27 Billion | 14.53 Billion | 13.12 Billion | 10.46 Billion | 5.03 Billion | 3.86 Billion |
| Capital Expenditure | -1.48 Billion | -1.99 Billion | -1.66 Billion | -554.32 Million | -561.35 Million | -529.1 Million |
| Effect of forex changes on cash | 12.53 Million | 80.49 Million | -16.86 Million | -89.07 Million | 12.3 Million | 53.78 Million |
| Net cash flow / Change in cash | 5.73 Billion | 1.41 Billion | 2.65 Billion | 5.43 Billion | 1.16 Billion | -395.9 Million |
| Free Cash Flow | 6.15 Billion | -726.91 Million | 2.55 Billion | 2.87 Billion | 3.25 Billion | 2.24 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.18 Billion | 2.06 Billion | 1.36 Billion | 4.27 Billion | 828.65 Million | 1.16 Billion |
| Depreciation & Amortization | - | 212.41 Million | 212.41 Million | 704.63 Million | 222.45 Million | -303.45 Million |
| Deferred income taxes | - | - | - | -98.47 Million | -2.36 Billion | 570.62 Million |
| Stock-based compensation | - | 109.86 Million | - | 166.65 Million | 166.65 Million | -100.05 Million |
| Change in working capital | - | -2.36 Billion | - | 2.38 Billion | 2.22 Billion | -186.22 Million |
| Other non-cash items | 372.67 Million | -46.03 Million | -114.33 Million | 279.3 Million | 2.28 Billion | 287.1 Million |
| Investing Cash Flow | -349.85 Million | -799.41 Million | -750.39 Million | 1.22 Billion | -15.27 Million | 239.37 Million |
| Investments in PPE | -559.99 Million | -403.65 Million | -561.02 Million | -1.48 Billion | -113.31 Million | -385.19 Million |
| Acquisitions | 2.32 Million | 4.23 Million | 0.06 | 0.29 | 0.12 | 8.87 Million |
| Investment purchases | - | -400 Million | -200 Million | -17.08 Million | -14.91 Million | -8.87 Million |
| Sales/Maturities of investments | 207.81 Million | 26.21 Million | 9 Million | 2.7 Billion | 106.01 Million | 615.7 Million |
| Other Investing Activities | 2.32 Million | -369.55 Million | 1.62 Million | 20.18 Million | 6.95 Million | 8.87 Million |
| Financing Cash Flow | -1.36 Billion | -120.43 Million | -18.13 Million | -3.14 Billion | -54.48 Million | -468.12 Million |
| Debt repayment | - | - | - | -1.26 Billion | -16.1 Million | -6.1 Million |
| Dividends payments | -1.27 Billion | - | - | -1.01 Billion | -1.01 Billion | -39.18 Million |
| Common Stock Repurchased | 110.16 Million | -110.16 Million | - | -827.26 Million | -827.26 Million | 370.38 Million |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -94.18 Million | 17.11 Million | -18.13 Million | -861.59 Million | -38.21 Million | -435.04 Million |
| Accounts receivables | - | -2.54 Billion | - | 2.03 Billion | 2.03 Billion | -138.97 Million |
| Accounts payables | - | - | - | 315.32 Million | - | 90.05 Million |
| Inventory | - | 77.83 Million | - | 129.1 Million | 129.1 Million | -47.24 Million |
| Other working capital | - | 109.86 Million | - | -98.47 Million | 55.46 Million | -90.05 Million |
| Cash at beginning of period | 21.63 Billion | 21.3 Billion | 20.27 Billion | 14.53 Billion | 17.01 Billion | 15.81 Billion |
| Cash at end of period | 21.45 Billion | 22.31 Billion | 20.73 Billion | 20.27 Billion | 20.27 Billion | 17.01 Billion |
| Capital Expenditure | -559.99 Million | -403.65 Million | -561.02 Million | -1.48 Billion | -113.31 Million | -385.19 Million |
| Effect of forex changes on cash | -15.38 Million | 12.36 Million | -18.2 Million | 12.53 Million | -7.16 Million | -8 Million |
| Net cash flow / Change in cash | -180.5 Million | 1 Billion | 467.86 Million | 5.73 Billion | 3.25 Billion | 1.19 Billion |
| Free Cash Flow | 1 Billion | 1.4 Billion | 693.57 Million | 6.15 Billion | 3.22 Billion | 1.04 Billion |
4651
DYA
6797
FACORALL
ISI
SRBIF